Literature DB >> 6123654

Ceftazidime in cystic fibrosis.

B Gordts, I Dab, J P Butzler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6123654     DOI： 10.1016/s0140-6736(82)92417-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Treatment of respiratory tract infections with cephalosporin antibiotics.

Authors:  R Finch
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  [Comparative in vitro study of the antimicrobial activity of ceftazidime against clinical isolates].

Authors:  W Klietmann; J Focht; K Nösner
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 3.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

4.  Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms.

Authors:  N Clumeck; Y Van Laethem; B Gordts; N Jaspar; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.